Comprehensive Clinical Management: Focus on Patients With Spasticity

On-Line Course
Duration: 4-1/2 hours
CME credits/CEU: 5.25 CME credits / 0.4 CEU
Valid for credit from May 26, 2021 to May 26, 2022

In order to earn CME credit/CEU and receive a CME certificate for this activity

  1. View all the video modules in this activity and evaluate the content presented
  2. Complete and submit the CME post-test and post-activity survey/evaluation form
  3. Participants requiring AOTA CEU should complete and submit the OT Post-Test along with post-activity survey/evaluation form
  4. Once you have completed the post-test and survey/evaluation, you will receive an email with a link to retrieve your CME or CEU certificate.

Course Description
This Comprehensive Clinical Management course provides clinically relevant education that fosters an integrated and comprehensive interdisciplinary approach to achieve the best clinical outcomes for patients with spasticity using a combination of neurotoxin therapy and appropriate follow-up care.

The course content features didactic presentations with Q & A, as well as video grand rounds featuring patients with spasticity, and an interactive expert panel discussion.


Welcome and Program Overview
Managing Patients with Spasticity: From Evidence to Best Practice
Cindy Ivanhoe, MD
Guidance, Localization and Placement of Botulinum Toxin What Works Best? (Pediatric & Adult Limb Spasticity)
Katharine Alter, MD
Optimizing Patient Outcomes Post-BoNT Using Rehabilitation Therapy
Laura Wiggs, PT, NCS, CBIS
The Speech Language Pathologist’s Perspective:
A Key Member of the Comprehensive Clinical Management Team
Sofia Tilton, MS, CCC-SLP
Interactive Video Grand Rounds: Patient Assessments, Neurotoxin Injections, Rehabilitation Therapy and Recommendations for Aftercare
The Treatment Team
(Cindy Ivanhoe, Katharine Alter, Laura Wiggs, Sofia Tilton & Craig Davis)


Learning Objectives:

  • Recognize the importance, benefits, challenges, and practical concerns regarding the interdisciplinary team approach for management of patients with spasticity, in order to develop individualized treatment plans
  • Interpret the clinical evidence, guidelines, and recommendations on the use of neurotoxins and adjunctive rehabilitation interventions (PT/OT/SLP), both alone and in combination, in order to establish appropriate treatment strategies for these patients
  • Assess neuromuscular pathology and individual patient functional goals, in order to identify appropriate muscles, determine dosing, maximize therapeutic benefit, and minimize complications
  • Evaluate methods of guidance and localization (ie, EMG, e-stim, ultrasound), in order to incorporate best practices for proper placement of neurotoxin
  • Facilitate interaction and improve communication among members of the interdisciplinary treatment team, in order to encourage appropriate referrals for both neurotoxin injection and adjunctive therapy that may optimize patient outcomes

Target Audience:
Physiatrists, neurologists, physical therapists, occupational therapists, speech-language pathologists, and other healthcare professionals who manage patients with spasticity.

This activity is appropriate for OT participants at all levels: introductory, intermediate, and advanced.

This course is intended for healthcare professionals only.

Registration Details

Tuition Fee: $29.00

Tuition fee is waived for Residents/Fellows who provide a copy of their staff badge or other credential.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Utah and Scientiae, LLC.

The University of Utah is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit: The University of Utah School of Medicine designates this other activity: virtual or on demand for a maximum of 5.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOTA Credit: Scientiae, LLC, is an AOTA Approved Provider of professional development. Course approval ID# 1947. This Distance Learning — Interactive Course is offered at 0.4 CEU.

All attendees are encouraged to use the CME system to claim their attendance. Physicians will be awarded AMA PRA Category 1 Credit(s)™; all other professions will be awarded attendance at a CME event credit that they may use for their re‐credentialing purposes. All users will be able to print or save certificates. For questions regarding the CME system, please contact the University of Utah Continuing Medical Education Office. For questions regarding re‐credentialing process or requirements, please contact your re-credentialing organization.

Nondiscrimination and Disability Accommodation Statement:
The University of Utah does not exclude, deny benefits to or otherwise discriminate against any person on the basis of race, color, national origin, sex, disability, age, veteran’s status, religion, gender identity/expression, genetic information, or sexual orientation in admission to or participation in its programs and activities. Reasonable accommodations will be provided to qualified individuals with disabilities upon request, with reasonable notice. Requests for accommodations or inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 201 S President’s Circle, RM 135, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).

Conflict of Interest Statement: As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), The University of Utah School of Medicine Continuing Medical Education Office (UUCME) meets the ACCME Standards for Integrity and Independence expectations. UUCME requires everyone in control of content, including all speakers and planners, to disclose financial relationships with ACCME-defined ineligible companies in any amount within the past 24 months and any relevant financial relationships must be mitigated prior to the activity start.

Disclosure: Neither planners, speakers, or anyone in control of content have any relevant financial relationships with an ACCME-defined ineligible company to disclose or mitigate.


Carol Tucker, MSc
Senior Vice President, Scientific Affairs
Scientiae LLC
New York, New York


Utah Health | ACCME | Scientiae

This activity is jointly provided by the University of Utah School of Medicine and Scientiae, LLC.


AOTA Accreditation:

Scientiae is an AOTA-Approved Provider of accredited OT CEU, approved in the areas of Live Activities, Distance Learning -Interactive, and Distance Learning – Independent. Our AOTA Approved Provider Number is 6346.


Supported by an independent educational grant from Allergan, an AbbVie company.